@prefix epid: .
@prefix dc: .
@prefix geo: .
@prefix bibo: .
@prefix owl: .
@prefix void: .
@prefix event: .
@prefix skos: .
@prefix xsd: .
@prefix cc: .
@prefix ep: .
@prefix foaf: .
@prefix rdf: .
@prefix rdfs: .
@prefix eprel: .
@prefix dct: .
<>
foaf:primaryTopic ;
rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .
rdfs:label "Das_10_MD.pdf"^^xsd:string .
rdfs:label "small.png"^^xsd:string .
rdfs:label "preview.jpg"^^xsd:string .
rdfs:label "indexcodes.txt"^^xsd:string .
rdfs:label "preview.png"^^xsd:string .
dc:format "text/html";
dc:title "HTML Summary of #1475 Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors";
foaf:primaryTopic .
dct:hasPart ;
ep:hasFile ;
eprel:hasIndexCodesVersion ;
eprel:hasVersion ,
,
,
;
eprel:hasVolatileVersion ,
,
,
;
eprel:haspreviewThumbnailVersion ,
;
eprel:hassmallThumbnailVersion ;
rdf:type bibo:Document,
ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (PDF)"^^xsd:string .
eprel:hasIndexCodesVersion ;
eprel:hasVersion ,
,
,
;
eprel:hasVolatileVersion ,
,
,
;
eprel:haspreviewThumbnailVersion ,
;
eprel:hassmallThumbnailVersion ;
rdf:type bibo:Document,
ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (PDF)"^^xsd:string .
dct:hasPart ;
ep:hasFile ;
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
eprel:issmallThumbnailVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Thumbnail (Small))"^^xsd:string .
dct:hasPart ;
ep:hasFile ;
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
eprel:ispreviewThumbnailVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Image (JPEG))"^^xsd:string .
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
eprel:issmallThumbnailVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Thumbnail (Small))"^^xsd:string .
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
eprel:ispreviewThumbnailVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Image (JPEG))"^^xsd:string .
dct:hasPart ;
ep:hasFile ;
eprel:isIndexCodesVersionOf ;
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Indexer Terms)"^^xsd:string .
eprel:isIndexCodesVersionOf ;
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Indexer Terms)"^^xsd:string .
dct:hasPart ;
ep:hasFile ;
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
eprel:ispreviewThumbnailVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Image (PNG))"^^xsd:string .
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
eprel:ispreviewThumbnailVersionOf ;
rdf:type ep:Document;
rdfs:label "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors (Image (PNG))"^^xsd:string .
rdf:_1 .
bibo:abstract "The relationship between antiretroviral treatment of HIV infection, body fat distribution, insulin resistance (HOMA), adipocytokine and apolipoprotein-B (apoB) kinetics was investigated in 12 HIV negative controls and 55 HIV-infected patients including antiretroviral treatment-naïve patients (n=15) and patients taking two nucleoside analogues plus either a protease inhibitor (PI, n=15) or non-nucleoside reverse transcriptase inhibitor (NNRTI, n = 25). The HIV positive treatment groups had mild dyslipidaemia. The apo-B fractional clearance rate (FCR) was reduced in the HIV positive groups. Peripheral fat was lower in treated patients and correlated with duration of therapy. There was a positive correlation between peripheral fat and apo-B clearance rate and a negative correlation with apo-B pool size. Adiponectin was reduced in all HIV positive groups and correlated positively with HDL-cholesterol, apo-B FCR and limb fat and correlated negatively with plasma triglycerides and HOMA. In a linear regression model which included HOMA, adiponectin level but not HOMA was predictive of apo-B FCR and HDL cholesterol. These results suggest that mild dyslipidaemia resulting from antiretroviral therapy is due to a decrease in apo-B FCR which is strongly related to loss of peripheral fat. Adiponectin may have a direct effect on lipoprotein metabolism which may be independent of insulin."^^xsd:string;
bibo:authorList ;
bibo:status ;
dct:creator ,
;
dct:date "2010-07";
dct:isPartOf ;
dct:issuer ,
;
dct:subject ,
;
dct:title "Mechanism of lipid disorder in HIV infection: apolipoprotein-B kinetics, fat distribution, insulin resistance and adipocytokines in patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors"^^xsd:string;
ep:hasDocument ,
,
,
,
,
,
,
,
,
;
rdf:type bibo:Article,
bibo:Thesis,
ep:EPrint,
ep:ThesisEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "RC Internal medicine"@en .
rdf:type skos:Concept;
skos:prefLabel "RD Surgery"@en .
dct:isPartOf ;
foaf:name "School of Medicine, University of Birmingham"^^xsd:string;
rdf:type foaf:Organization .
dct:hasPart ;
foaf:name "University of Birmingham"^^xsd:string;
rdf:type foaf:Organization .
foaf:familyName "Das"^^xsd:string;
foaf:givenName "Satyajit"^^xsd:string;
foaf:name "Satyajit Das"^^xsd:string;
rdf:type foaf:Person .